Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Broker tips: Bridgepoint, Kooth, Close Brothers
(Sharecast News) - Citi upgraded its stance on private equity firm Bridgepoint on Friday to 'buy' from 'neutral' as it said the share price fall was overdone. The bank noted that in its initiation report, it observed the strong growth opportunity available to Bridgepoint in the mid-market private asset space, but argued the valuation was rich relative to peers.
"The subsequent fall in the share price means this is no longer the case," it said. "Even after the bounce following the FY21 earnings beat the stock is still only trading on 23x 2023E price-to-earnings, so we see this as a more attractive entry point."
Analysts at Canaccord Genuity lowered their target price on mental health care specialist Kooth from 470.0p to 380.0p on Friday following the firm's results earlier in the week.
Canaccord Genuity said Kooth's 2021 full-year results confirmed ongoing momentum for the company, with revenues up 28% year-on-year to £16.7m, slightly ahead of expectations, and gross margins remained broadly flat at 69.5%, as one-off Covid-19 benefits reversed to normalised levels.
The Canadian bank stated that following on from the reclassification of clinical engagement costs to indirect marketing spend, Kooth's margins now sit a level above industry peers as it benefits from operational efficiencies from the platform.
However, Canaccord said its 2022 full-year sales forecast assumed a slower pace of growth for Kooth at 21%, in line with the 20% annual recurring revenue growth achieved in 2021, as high CYP market share gains temper.
"Nonetheless, industry demand is set to continue, as digital transformation tailwinds continue within the NHS (as set out in our recent sector update), compounded by the rising demand for mental health services both domestically and internationally," said the analysts, who stood by their 'buy' rating on the stock.
Liberum upgraded Close Brothers to 'buy' from 'hold' on Friday, arguing that the recent share price fall was overdone.
It said: "Although Russia's invasion of Ukraine may lead to lower economic growth in the short-term, with the market expecting the UK base rate to rise to 2.0% by year-end, banks are at long last set to benefit from economic tailwinds.
"This, coupled with the potential for further Covid-19 provision releases, should lead to earnings beating estimates, which remain conservative. We continue to prefer the specialist lenders, as they have carved out niches and are becoming leaders in their respective markets, such as BTL mortgages and SME lending."
Liberum, which left its price target for Close Bros unchanged at 1,490.0p, said the firm has a resilient and time-tested business model of lending conservatively at good margins. Despite this, loan growth over the last 18 months has been "impressive", helped by government support schemes and cash flow deficits at SMEs.
"Moreover, the net interest margin has improved, evidencing continued pricing discipline. The group has outperformed peers during downturns and with the current uncertainty and trading at FY22E P/TBV of 1.2x and a P/E of 8.6x for return on tangible equity of 14.6%, and with a dividend yield of 5.8% we believe the recent share price fall is overdone."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.